BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/29/2021 2:12:02 AM | Browse: 648 | Download: 1834
 |
Received |
|
2021-01-31 13:02 |
|
Peer-Review Started |
|
2021-01-31 13:13 |
|
First Decision by Editorial Office Director |
|
2021-03-14 06:00 |
|
Return for Revision |
|
2021-03-14 06:00 |
|
Revised |
|
2021-03-25 05:50 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-04-02 12:36 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-04-02 19:14 |
|
Articles in Press |
|
2021-04-02 19:14 |
|
Edit the Manuscript by Language Editor |
|
2021-04-12 20:02 |
|
Typeset the Manuscript |
|
2021-04-27 01:39 |
|
Publish the Manuscript Online |
|
2021-04-29 02:12 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Dan-Hong Yang, Wei-Ping Wang, Qiang Zhang, Hong-Ying Pan, Yi-Cheng Huang and Jia-Jie Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Zhejiang Provincial Natural Science Foundation |
LY18H190002 |
|
| Corresponding Author |
Dan-Hong Yang, PhD, Chief Doctor, Department of Infectious Diseases, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, No. 158 Shangtang Road, Hangzhou 310014, Zhejiang Province, China. ydh-11@163.com |
| Key Words |
Hepatitis B virus; Hepatocellular carcinoma; Cirrhosis; Risk factors; Nucleos(t)ide analogs; Progression |
| Core Tip |
This is a retrospective cross-sectional study to analyze risk factors of Hepatocellular carcinoma (HCC) progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy for at least 6 mo. We discussed the diagnostic value of the serum alpha-fetoprotein level was evaluated in those patients. The results of the present study increase our understanding of HCC pathogenesis and help to provide HCC prevention and control strategies. |
| Publish Date |
2021-04-29 02:12 |
| Citation |
Yang DH, Wang WP, Zhang Q, Pan HY, Huang YC, Zhang JJ. Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study. World J Gastroenterol 2021; 27(17): 2025-2038 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i17/2025.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i17.2025 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
